For example, postoperative chemotherapy might be useful for CK18-expressing pStage II/III tumours and pStage IV tumours regardless of CK18 expression, but not for pStage I tumours and CK18-negative pStage II/III tumours. This evidence concerns the gene KRT18 and neoplasm.